Growth Metrics

Enovis (ENOV) Cash from Investing Activities Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn -15.58%

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 -15.58%
Dec 31, 2025 29.50%
Oct 3, 2025 1.77%
Jul 4, 2025 -3.43%
Apr 4, 2025 -19.84%
Dec 31, 2024 -29.22%
Sep 27, 2024 -39.44%
Jun 28, 2024 34.05%
Mar 29, 2024 -84.03%
Dec 31, 2023 13.25%
Sep 29, 2023 18.11%
Jun 30, 2023 -103.04%
Mar 31, 2023 2.64%
Dec 31, 2022 -26.48%
Sep 30, 2022 -40.88%
Jul 1, 2022 -6.15%
Apr 1, 2022 77.70%
Dec 31, 2021 50.38%
Oct 1, 2021 21.90%
Jul 2, 2021 -43.48%
Apr 2, 2021 -33.28%
Dec 31, 2020 -36.50%
Oct 2, 2020 -22.53%
Jul 3, 2020 31.51%
Apr 3, 2020 -47.08%
Dec 31, 2019 246.51%
Sep 27, 2019 -9.35%
Jun 28, 2019 -54.98%
Mar 29, 2019 -490.64%
Dec 31, 2018 -94.76%
Sep 28, 2018 38.97%
Jun 29, 2018 184.83%
Mar 30, 2018 -69.21%
Dec 31, 2017 111.88%
Sep 29, 2017 -0.18%
Jun 30, 2017 63.16%
Mar 31, 2017 2.40%
Dec 31, 2016 53.85%
Sep 30, 2016 17.68%
Jul 1, 2016 16.98%
Apr 1, 2016 5.05%
Dec 31, 2015 46.15%
Sep 25, 2015 -60.67%
Jun 26, 2015 37.98%
Mar 27, 2015 81.17%
Dec 31, 2014 15.50%
Sep 26, 2014 -57.14%
Jun 27, 2014 -564.07%
Mar 28, 2014 20.79%
Dec 31, 2013 -363.64%
Sep 27, 2013 2.07%